FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for Geodon (ziprasidone) from Viatris Specialty LLC, indicating a regulatory action to modify or update the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Geodon (Ziprasidone)

Snippet

SUPPL AP for GEODON (ZIPRASIDONE MESYLATE)